Evidence map›Paper›PMID 29194116›Full record

ArticleAIDS (London, England)2018

Preexposure prophylaxis guidelines have low sensitivity for identifying seroconverters in a sample of young Black MSM in Chicago.

Nicola Lancki, Ellen Almirol, Leigh Alon, Moira McNulty, John A Schneider

Abstract readEvaluation Study
In one paragraph

Article in AIDS (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicola LanckiDepartment of Medicine, University of Chicago.
Ellen AlmirolDepartment of Medicine, University of Chicago.
Leigh AlonDepartment of Medicine, University of Chicago.
Moira McNultyDepartment of Medicine, University of Chicago.
John A SchneiderDepartment of Medicine, University of Chicago.

Funding

HIV intervention models for criminal justice involved substance-using Black MSMR01DA039934 · NIDA · UNIVERSITY OF CHICAGO · PI FUJIMOTO, KAYO, HARAWA, NINA THAWATA · 2015 to 2019
$3.6M
Social Network Dynamics, HIV, and Risk Reduction Among Younger Black MSMR01DA033875 · NIDA · NATIONAL OPINION RESEARCH CENTER · PI SCHNEIDER, JOHN · 2012 to 2016
$3.0M
Accelerating PrEP Diffusion through Network Change AgentsR01AI120700 · NIAID · UNIVERSITY OF CHICAGO · PI SCHNEIDER, JOHN · 2015 to 2019
$2.2M
NIAID NIH HHS R01 AI120700NIDA NIH HHS R01 DA033875NIDA NIH HHS R01 DA039934
6 · The paper itself

Abstract

backgroundIdentification of clients at greatest risk of acquiring HIV is critical for preexposure prophylaxi (PrEP) implementation. Young black MSM (YBMSM) have high incidence of HIV. We examined published guidelines in identifying eligible PrEP candidates, including seroconverters, in a representative cohort of YBMSM.

methodsThe uConnect cohort included YBMSM aged 16-29 years during PrEP roll-out in Chicago from 2013 and 2016. YBMSM with indications for PrEP were determined using Center for Disease Control and Prevention (CDC) guidelines, the HIV incidence risk index for MSM (HIRI-MSM) scoring tool, and Gilead recommendations with calculation of sensitivities, specificities, and area under the curve (AUC) for HIV seroconversion over 18 months. Incidence rate ratios (IRRs) using Poisson regression were modeled to compare individual and network factors associated with seroconversion.

resultsIn the study cohort, 300 HIV uninfected YBMSM contributed 390.4 person-years of follow-up [mean age (SD), 22.3 years (3.07)]. HIV incidence was 8.5 cases per 100 person-years (95% confidence interval, 6.0-11.9). One network factor was associated with seroconversion: having partners more than 10 years older (IRR = 4.4, 95% confidence interval, 1.6-11.8). Overall, 49% of the cohort had an indication for PrEP using CDC guidelines; 72% using HIRI-MSM, and 86% using Gilead recommendations. HIV seroconverters (n = 33) were identified as PrEP eligible prior to seroconversion with sensitivities/AUCs for CDC (52%/0.51), HIRI-MSM (85%/0.57), and Gilead guidelines (94%/0.54).

conclusionLow sensitivity of CDC guidelines and limited AUC of HIRI-MSM and Gilead screening tools are of concern for PrEP implementation among most at risk populations such as YBMSM. Consideration of demographics, local epidemiology, and network factors may better guide identification of clients who could benefit most from PrEP.

Indexed as

Epidemiologic MethodsAdolescentAdultBlack or African AmericanBlack PeopleChicagoDisease Transmission, InfectiousFollow-Up StudiesHIV InfectionsHomosexuality, MaleHumansIncidenceMalePre-Exposure ProphylaxisRisk AssessmentSensitivity and Specificity

Identifiers

PMID29194116
PMCPMC5758406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.